STOCK TITAN

[8-K] ALT5 Sigma Corp Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

ALT5 Sigma Corporation reported that stockholders approved an amendment to increase authorized common stock from 200,000,000 to 2,000,000,000 shares. The vote at the reconvened Special Meeting on October 16, 2025 passed with 56,829,178 votes for, 13,099,874 against, and 4,646 abstentions. The company plans to file the amendment with the Secretary of State of Nevada.

As context, there were 109,620,596 shares of common stock outstanding and 883,667 shares of voting preferred stock outstanding as of August 12, 2025, the record date. No other matters were voted on at the reconvened Special Meeting.

ALT5 Sigma Corporation ha riferito che gli azionisti hanno approvato una modifica per aumentare il capitale azionario autorizzato da 200.000.000 a 2.000.000.000 azioni. Il voto nella riunione speciale riconvocata del 16 ottobre 2025 è passato con 56.829.178 voti favorevoli, 13.099.874 contrari e 4.646 astensioni. L'azienda prevede di presentare la modifica al Segretario di Stato del Nevada.

Per contesto, al 12 agosto 2025 erano in circolazione 109.620.596 azioni ordinarie e 883.667 azioni privilegiate votanti in circolazione, come data di registrazione. Non sono stati votati altri argomenti durante la riunione speciale riconvocata.

ALT5 Sigma Corporation informó que los accionistas aprobaron una enmienda para aumentar el capital social autorizado de 200,000,000 a 2,000,000,000 acciones. La votación en la Reunión Especial reconvocada del 16 de octubre de 2025 fue aprobada con 56,829,178 votos a favor, 13,099,874 en contra y 4,646 abstenciones. La empresa planea presentar la enmienda ante el Secretario de Estado de Nevada.

Como contexto, había 109,620,596 acciones comunes en circulación y 883,667 acciones preferentes con derecho a voto en circulación a la fecha de registro del 12 de agosto de 2025. No se votaron otros asuntos en la reunión especial reconvocada.

ALT5 Sigma Corporation은 주주들이 주식의 승인을 가능한 보통주를 2억 주에서 20억 주로 증가시키는 수정안을 승인했다고 발표했습니다. 2025년 10월 16일 재소집된 특별회의에서 찬성 56,829,178표, 반대 13,099,874표, 기권 4,646표로 가결되었습니다. 회사는 네바다 주 국무장관에게 수정안을 제출할 계획입니다.

참고로 기록일인 2025년 8월 12일 현재 유통 중인 보통주 109,620,596주와 의결권이 있는 우선주 883,667주가 있었습니다. 재소집된 특별회의에서 다른 안건은 투표되지 않았습니다.

ALT5 Sigma Corporation a annoncé que les actionnaires ont approuvé un amendement visant à augmenter le capital social autorisé de 200 000 000 à 2 000 000 000 actions. Le vote lors de la Réunion spéciale reconvoquée du 16 octobre 2025 s’est soldé par 56 829 178 voix pour, 13 099 874 voix contre et 4 646 abstentions. La société prévoit de déposer l’amendement auprès du Secrétaire d’État du Nevada.

Pour contexte, au 12 août 2025 il y avait 109 620 596 actions ordinaires en circulation et 883 667 actions privilégiées avec droit de vote en circulation, à la date d’enregistrement. Aucun autre sujet n’a été soumis au vote lors de la réunion spéciale reconvoquée.

ALT5 Sigma Corporation berichtete, dass die Aktionäre einer Änderung zugestimmt haben, das autorisierte Grundkapital von 200.000.000 auf 2.000.000.000 Aktien zu erhöhen. Die Abstimmung bei der erneut einberufenen Sondersitzung am 16. Oktober 2025 wurde mit 56.829.178 Zustimmungen, 13.099.874 Ablehnungen und 4.646 Enthaltungen angenommen. Das Unternehmen plant, die Änderung beim Secretary of State des Bundesstaates Nevada einzureichen.

Als Kontext gab es am 12. August 2025 109.620.596 ausstehende Stammaktien und 883.667 ausstehende stimmberechtigte Vorzugsaktien. Kein weiteres Thema wurde bei der erneut einberufenen Sondersitzung abgestimmt.

أفادت شركة ALT5 Sigma بأن المساهمين وافقوا على تعديل لزيادة رأس المال العادي المصرح به من 200,000,000 إلى 2,000,000,000 سهم. تم تمرير التصويت في الاجتماع الخاص المعاد عقده في 16 أكتوبر 2025 بأصوات 56,829,178 موافقون، 13,099,874 معترضون، و4,646 امتناعًا. تخطط الشركة لتقديم التعديل إلى أمين ولاية نيفادا.

للتوضيح، كان هناك 109,620,596 سهمًا عاديًا قائمًا و883,667 سهمًا من الأسهم الممتازة ذات حق التصويت قائمًا حتى تاريخ التسجيل في 12 أغسطس 2025. لم تتم مناقشة أي مواضيع أخرى في الاجتماع الخاص المعاد عقده.

Positive
  • None.
Negative
  • None.

Insights

Shareholders approved a major increase in authorized shares.

Stockholders approved raising authorized common shares from 200,000,000 to 2,000,000,000. This action expands the company’s capacity to issue equity for future corporate purposes such as financing, strategic transactions, or equity plans, as permitted by law and board decisions.

The resolution passed with 56,829,178 votes for versus 13,099,874 against, indicating clear support among voting holders. As of August 12, 2025, 109,620,596 common shares were outstanding, which serves as a baseline figure separate from the newly authorized capacity.

Actual effects depend on if and when new shares are issued under this expanded authorization. The company stated it plans to file the amendment with the Secretary of State of Nevada.

ALT5 Sigma Corporation ha riferito che gli azionisti hanno approvato una modifica per aumentare il capitale azionario autorizzato da 200.000.000 a 2.000.000.000 azioni. Il voto nella riunione speciale riconvocata del 16 ottobre 2025 è passato con 56.829.178 voti favorevoli, 13.099.874 contrari e 4.646 astensioni. L'azienda prevede di presentare la modifica al Segretario di Stato del Nevada.

Per contesto, al 12 agosto 2025 erano in circolazione 109.620.596 azioni ordinarie e 883.667 azioni privilegiate votanti in circolazione, come data di registrazione. Non sono stati votati altri argomenti durante la riunione speciale riconvocata.

ALT5 Sigma Corporation informó que los accionistas aprobaron una enmienda para aumentar el capital social autorizado de 200,000,000 a 2,000,000,000 acciones. La votación en la Reunión Especial reconvocada del 16 de octubre de 2025 fue aprobada con 56,829,178 votos a favor, 13,099,874 en contra y 4,646 abstenciones. La empresa planea presentar la enmienda ante el Secretario de Estado de Nevada.

Como contexto, había 109,620,596 acciones comunes en circulación y 883,667 acciones preferentes con derecho a voto en circulación a la fecha de registro del 12 de agosto de 2025. No se votaron otros asuntos en la reunión especial reconvocada.

ALT5 Sigma Corporation은 주주들이 주식의 승인을 가능한 보통주를 2억 주에서 20억 주로 증가시키는 수정안을 승인했다고 발표했습니다. 2025년 10월 16일 재소집된 특별회의에서 찬성 56,829,178표, 반대 13,099,874표, 기권 4,646표로 가결되었습니다. 회사는 네바다 주 국무장관에게 수정안을 제출할 계획입니다.

참고로 기록일인 2025년 8월 12일 현재 유통 중인 보통주 109,620,596주와 의결권이 있는 우선주 883,667주가 있었습니다. 재소집된 특별회의에서 다른 안건은 투표되지 않았습니다.

ALT5 Sigma Corporation a annoncé que les actionnaires ont approuvé un amendement visant à augmenter le capital social autorisé de 200 000 000 à 2 000 000 000 actions. Le vote lors de la Réunion spéciale reconvoquée du 16 octobre 2025 s’est soldé par 56 829 178 voix pour, 13 099 874 voix contre et 4 646 abstentions. La société prévoit de déposer l’amendement auprès du Secrétaire d’État du Nevada.

Pour contexte, au 12 août 2025 il y avait 109 620 596 actions ordinaires en circulation et 883 667 actions privilégiées avec droit de vote en circulation, à la date d’enregistrement. Aucun autre sujet n’a été soumis au vote lors de la réunion spéciale reconvoquée.

ALT5 Sigma Corporation berichtete, dass die Aktionäre einer Änderung zugestimmt haben, das autorisierte Grundkapital von 200.000.000 auf 2.000.000.000 Aktien zu erhöhen. Die Abstimmung bei der erneut einberufenen Sondersitzung am 16. Oktober 2025 wurde mit 56.829.178 Zustimmungen, 13.099.874 Ablehnungen und 4.646 Enthaltungen angenommen. Das Unternehmen plant, die Änderung beim Secretary of State des Bundesstaates Nevada einzureichen.

Als Kontext gab es am 12. August 2025 109.620.596 ausstehende Stammaktien und 883.667 ausstehende stimmberechtigte Vorzugsaktien. Kein weiteres Thema wurde bei der erneut einberufenen Sondersitzung abgestimmt.

أفادت شركة ALT5 Sigma بأن المساهمين وافقوا على تعديل لزيادة رأس المال العادي المصرح به من 200,000,000 إلى 2,000,000,000 سهم. تم تمرير التصويت في الاجتماع الخاص المعاد عقده في 16 أكتوبر 2025 بأصوات 56,829,178 موافقون، 13,099,874 معترضون، و4,646 امتناعًا. تخطط الشركة لتقديم التعديل إلى أمين ولاية نيفادا.

للتوضيح، كان هناك 109,620,596 سهمًا عاديًا قائمًا و883,667 سهمًا من الأسهم الممتازة ذات حق التصويت قائمًا حتى تاريخ التسجيل في 12 أغسطس 2025. لم تتم مناقشة أي مواضيع أخرى في الاجتماع الخاص المعاد عقده.

ALT5 Sigma Corporation宣布,股东通过了一项修订,将授权普通股的数量从2亿股增加到20亿股。复会的特别会议在2025年10月16日的投票以56,829,178票同意、13,099,874票反对、4,646票弃权通过。公司计划将修订案提交给内华达州国务卿。

作为背景,截至2025年8月12日的登记日,已发行在外的普通股为109,620,596股,且有投票权的优先股为883,667股。复会的特别会议未就其他事项进行投票。

false 0000862861 0000862861 2025-10-16 2025-10-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) October 16, 2025

 

ALT5 SIGMA CORPORATION

(Exact name of registrant as specified in its charter)

 

Nevada   000-19621   41-1454591

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

325 E. Warm Spring Road, Suite 102

Las Vegas, NV

  89119
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code (702) 997-5968

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common stock (par value $0.001 per share)   ALTS   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

On October 16, 2025, at 1:00 P.M. Eastern Time, ALT5 Sigma Corporation (the “Company”) reconvened its Special Meeting of Stockholders (the “Special Meeting”) exclusively online via live webcast. The Special Meeting was previously convened and adjourned on October 10, 2025. As of August 12, 2025, the record date for the Special Meeting, there were 109,620,596 outstandings shares of the Company’s common stock and 883,667 outstanding shares of voting preferred stock. At the reconvened Special Meeting, stockholders voted on Proposal 3, to approve an amendment of the Company’s Articles of Incorporation, as amended, to increase the total number of authorized shares of common stock, from 200,000,000 shares to 2,000,000,000, as described in the Company’s Definitive Proxy Statement on Schedule 14A for the Special Meeting, filed with the U.S. Securities and Exchange Commission on September 26, 2025. The results of Proposal 3, which take into account both the shares of common stock and shares of voting preferred stock, are as follows:

 

(a) Proposal 3 - Approval of an amendment of the Company’s Articles of Incorporation, as amended, to increase the total number of authorized shares of common stock, from 200,000,000 shares to 2,000,000,000.

 

The votes with respect to the approval of an amendment of the Company’s Articles of Incorporation, as amended, to increase the total number of authorized shares of common stock, from 200,000,000 to 2,000,000,000, were as follows:

 

Votes For   Votes Against   Abstentions   Broker Non-Votes 
 56,829,178    13,099,874    4,646     

 

Based on the results set forth above, the stockholders approved an amendment to the Company’s Articles of Incorporation, as amended, to increase the total number of authorized shares of common stock, from 200,000,000 shares to 2,000,000,000 (the “Amendment”). The Company plans to file the Amendment with the Secretary of State of Nevada.

 

No other matters were voted on at the reconvened Special Meeting.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ALT5 SIGMA CORPORATION
   
Date: October 16, 2025 By: /s/ Jonathan Hugh
    Jonathan Hugh
    Chief Financial Officer

 

 

 

FAQ

What did ALT5 (ALTS) stockholders approve at the Special Meeting?

They approved increasing authorized common stock from 200,000,000 to 2,000,000,000 shares.

What were the vote results for ALT5’s share authorization increase?

Votes were 56,829,178 for, 13,099,874 against, and 4,646 abstentions.

When was the ALT5 Special Meeting held and how was it conducted?

It reconvened on October 16, 2025 and was held exclusively online via live webcast.

How many ALT5 shares were outstanding on the record date?

As of August 12, 2025, there were 109,620,596 common shares and 883,667 voting preferred shares outstanding.

Will ALT5 file the approved amendment with the state?

Yes. The company plans to file the amendment with the Secretary of State of Nevada.

Were any other matters voted on at the reconvened meeting?

No. No other matters were voted on.
ALT5 Sigma Corporation

NASDAQ:ALTS

ALTS Rankings

ALTS Latest News

ALTS Latest SEC Filings

ALTS Stock Data

258.64M
95.98M
11.13%
14.98%
5.55%
Software - Application
Pharmaceutical Preparations
Link
United States
LAS VEGAS